Showing results (281-290 of 670) with videos related to
Sort By:
Pageof 67
Lancet (London, England)|April 27, 1985
Normal MPTP binding in parkinsonian substantial nigra: evidence for extraneuronal toxin conversion in human brainG R Uhl, J A Javitch, S H SnyderJournal of Neurochemistry|February 1, 1987
Characterization of the binding of N-methyl-4-phenylpyridine, the toxic metabolite of the parkinsonian neurotoxin N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine, to neuromelaninR J D'Amato, D F Benham, S H SnyderNature|October 25, 1990
Localization of nitric oxide synthase indicating a neural role for nitric oxideD S Bredt, P M Hwang, S H SnyderAnnals of Neurology|September 1, 1992
A novel neuronal messenger molecule in brain: the free radical, nitric oxideT M Dawson, V L Dawson, S H SnyderArchives of Ophthalmology (Chicago, Ill. : 1960)|May 1, 1991
Ocular effects of the endothelins. Abundant peptides in the eyeM W MacCumber, H D Jampel, S H SnyderEuropean Journal of Pharmacology|May 13, 1986
Sigma receptors on NCB-20 hybrid neurotumor cells labeled with (+)[3H]SKF 10,047 and (+)[3H]3-PPPB L Largent, A L Gundlach, S H SnyderAnnals of Internal Medicine|February 1, 1994
Nitric oxide: a physiologic messengerC J Lowenstein, J L Dinerman, S H SnyderLife Sciences|December 26, 1983
A simple sensitive radioreceptor assay for calcium antagonist drugsR J Gould, K M Murphy, S H SnyderMolecular Pharmacology|September 1, 1984
Kinetic differences between type I and type II benzodiazepine receptorsR R Trifiletti, M M Lo, S H SnyderProceedings of the National Academy of Sciences of the United States of America|January 1, 1982
Physical separation and characterization of two types of benzodiazepine receptorsM M Lo, S M Strittmatter, S H SnyderPageof 67